What is Automatic Biopsy Systems Market Scope?
Biopsy has been one of the most important diagnosis techniques for cancer disorders and is widely used in the designation of breast, skin, and prostate cancer. With the increasing incidence of cancer cases and developments in biopsy systems, the market is anticipated to extend. There's additionally a requirement for minimally invasive biopsy procedures that are rising at a big rate within the market. The various styles of technologies and products, like biopsy guiding systems, needle-based biopsy guns, and vacuum-assisted devices are anticipated to witness high growth throughout the forecast amount. Additionally, the growing awareness relating to breast cancer treatment and designation can support the rise within the diagnostic assay devices market size in the future years. There are several countries that hold programs for the first designation of breast cancer. Therefore, such initiatives can accelerate the adoption rate of automatic biopsy systems, thereby completely impacting the expansion of the Automatic Biopsy Systems.
Influencing Trend:
Increasing Adoption of The System and High Recommendation from The Doctors
Market Growth Drivers:
Increasing Preference for Minimally Invasive Procedures and Increase in The Number of Cancer Cases Worldwide
Challenges:
Presence of Competitors and Lack of Skilled Professionals
Restraints:
High Cost of The System
Opportunities:
Initiatives Undertaken by Government for Diagnosis
The Automatic Biopsy Systems market study is being classified by Type (Aspiration Biopsy Needles, Vacuum-assisted Biopsy System, Localization Wires, Procedure Trays and Others), by Application and major geographies with country level break-up.
The market is increasing due to the increasing application and the demand from the hospitals. The growth in this market is primarily attributed to the rising prevalence of cancer, increasing demand for minimally invasive surgeries, initiatives undertaken by government & global health organizations to spread awareness about cancer, and the improved reimbursement scenario. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Automatic Biopsy Systems market throughout the predicted period.
C. R. Bard, Inc. (United States), Becton, Dickinson and Company (United States), Cook Group Incorporated (United States), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (United States), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (United States), Olympus Corporation (Japan), Boston Scientific Corporation (United States), FUJIFILM Holdings Corporation (Japan), INRAD, Inc. (United States) and Medtronic plc (Ireland) are some of the key players profiled in the study.
Segmentation Analysis
Analyst at AMA have segmented the market study of Global Automatic Biopsy Systems market by Type, Application and Region.
On the basis of geography, the market of Automatic Biopsy Systems has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Influencers and their Development Strategies
In February 2019, IZI Medical Products LLC, an interventional radiology medical device company and portfolio company of Shore Capital Partners LLC, acquired select soft tissue biopsy and breast localization needle assets from Cook Medical. The acquired product portfolio is marketed as the Quick-Core Biopsy Needle, MReye Breast Localization Coil, Kopans, and X-Reidy Lesion Localization Needle.
In September 2019, B. Braun Melsungen AG, a global leader in health technology and global leader in local anesthesia and pain management, launched Onvision, a groundbreaking ultrasound guidance solution for real-time needle tip tracking under local anesthesia. Available on the latest versions of the B. Braun and Philips Xperius ultrasound systems, Onvision gives anesthesiologists the confidence to accurately position the needle tip inside the body. This introduction is part of a multi-year strategic partnership between Philips and B. Braun to revolutionize ultrasound-guided local anesthesia, a rapidly growing alternative to general anesthesia.
Key Target Audience
Manufacturers of Automatic Biopsy Systems, Suppliers and distributors of Automatic Biopsy Systems, Governmental and Regulatory bodies, End-Users and Potential Investors
Automatic Biopsy Systems Market Study: Important Years
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Forecast Period | 2023-2028 |
Historical Period | 2018-2022 |
Unit | Value (USD Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
Major Highlights of Market Study
Demand Determinants: Identifying top-notch application and business segments that seek high growth potentials in Automatic Biopsy Systems Market.
Key Strategic Developments: To target untapped regions more aggressively by focusing on product/service developments, innovation and R & D, new launches, Merger & acquisitions, JVs & partnerships.
Forces & Market Dynamics: Growth drivers, restraints & opportunities available in Automatic Biopsy Systems industry is examined with reference relevant market sectors and sub-sectors.
Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also includes significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets, To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.